Autor: |
Jiménez-Mendoza, JC, Rivera-López, FE, González-Lara, MF, Valdez-Echeverría, RD, Castro-Narro, GE, Tore, A, Uscanga-Domínguez, LF, Moctezuma-Velázquez, C |
Zdroj: |
Annals of Hepatology; May-June 2022, Vol. 27 Issue: 3 |
Abstrakt: |
The emergence of SARS-CoV-2, which causes the coronavirus disease (COVID-19) has caused a great impact on healthcare systems worldwide, including hepatitis B and C viruses screening and elimination programs. The high number of COVID-19 hospitalizations represent a great opportunity to screen patients for hepatitis B virus (HBV) and hepatitis C virus (HCV), which was the aim of this study. |
Databáze: |
Supplemental Index |
Externí odkaz: |
|